JRSS JRSIS HEALTH CARE Corp

Overview and Growth

JRSIS HEALTH CARE Corp generated $3.46M of revenue in fiscal 2023, with net loss of $80.91K and an operating cash inflow of $516.72K. The $3.46M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line expanded 101.4% from $1.72M in fiscal 2022, increasing the company’s operating scale. Diluted earnings per share were -$0.00, translating the period’s attributable earnings into the amount reported for each diluted share. Total assets stood at $2.14M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 1.61x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The first profit layer was $483.05K of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 14.0% of revenue, showing how much of the top line remained after direct costs. The company recorded an operating loss of $188.60K after the reported operating expense base. The operating loss equaled 5.4% of revenue, showing the scale of the operating deficit relative to sales. The bottom-line result was a net loss of $80.91K after operating, financing, tax, and other recognized items. The net loss equaled 2.3% of revenue, showing the bottom-line deficit relative to the company’s sales base. The pretax result was a loss of $85.61K, establishing the deficit before tax effects. The pretax loss equaled 2.5% of revenue, measuring the pre-tax deficit against sales. The reported income-tax provision was $8.97K, the amount recognized between pretax income and the final net-income result. The loss-to-assets relationship was 3.8%, placing the bottom-line deficit against the company’s resource base.

Liquidity and Capital Structure

The company held $2.14M of assets against $2.31M of liabilities and -$160.65K of equity, revealing how the asset base was financed. Equity was negative at -$160.65K, meaning liabilities exceeded the residual book value available to shareholders and weakening balance-sheet resilience. The near-term balance sheet paired $1.83M of current assets with $2.28M of current liabilities at the reporting date. The current ratio was 0.8x; current liabilities exceeded current assets, leaving a short-term liquidity deficit. Reported cash and equivalents were $118.11K, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 5.2%, excluding receivables and other current assets. The company carried $43.66K of total debt at period end, which frames its leverage and debt-service burden. Relative to total assets, debt measured 2.0%, showing how much of the asset base was matched by borrowing. Relative to total assets, liabilities measured 107.5%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 5.5%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 5.1% from $2.04M in fiscal 2022, leaving current total assets higher year over year. Cash and equivalents were 25.6% lower than fiscal 2022 cash of $158.81K, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $516.72K, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. The cash-flow statement records $1.48K of capital expenditures, the investment amount considered after operating cash generation. Relative to operating cash flow, capital expenditures measured 0.3%, connecting investment intensity with the company’s cash-generation base. After capital spending, free cash flow was $515.24K, leaving cash available for debt reduction, shareholder returns, or further investment. The free-cash-flow margin was 14.9%, measuring cash remaining after capital spending against revenue. The free-cash-flow-to-assets relationship was 24.0%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Dec 31, 2023. Analysis generated Oct 21, 2026.